Table 3 CT-severity score at hospitalization and at 3-month follow-up visit; and pulmonary and exercise function tests at three-month follow-up visit
CT-SS at hospitalization | CT-SS at 3-month follow-up visit | |||||
|---|---|---|---|---|---|---|
Range CT-SS (minimum-maximum) | Mean CT-SS Mean (SD) | P-value* | Range CT-SS (minimum-maximum) | Mean CT-SS Mean (SD) | P-value* | |
Pulmonary function tests | ||||||
TLC | P = 0.041 | P < 0.001 | ||||
≥ 80% pred (n = 84 at hospitalization) (n = 87 at 3-month follow-up) | 6.5–23.5 | 14.8 (3.7) | 2.5–19.0 | 7.8 (3.8) | ||
< 80% pred (n = 22 at hospitalization) (n = 24 at 3-month follow-up) | 8.5–24.0 | 16.6 (4.0) | 2.5–18.5 | 11.2 (3.9) | ||
DLCO | P = 0.026 | P = 0.002 | ||||
> 80% pred (n = 42 at hospitalization) (n = 47 at 3-month follow-up) | 6.5–19.5 | 14.0 (3.9) | 2.5–17.5 | 7.4 (3.6) | ||
60–80% pred (n = 37 at hospitalization) (n = 36 at 3-month follow-up) | 8.0–23.0 | 15.4 (3.8) | 3.5–17.0 | 8.7 (3.5) | ||
40–60% pred (n = 22 at hospitalization) (n = 22 at 3-month follow-up) | 8.0–24.0 | 16.6 (4.7) | 3.0–18.5 | 9.4 (4.3) | ||
< 40% pred (n = 5 at hospitalization) (n = 6 at 3-month follow-up) | 12.5–22.0 | 17.4 (4.2) | 10.5–19.0 | 14.3 (3.2) | ||
Exercise function test | P = 0.284 | P = 0.098 | ||||
6MWT saturation ≥ 90% (n = 67 at hospitalization) (n = 71 at 3-month follow-up) | 6.5–23.5 | 14.8 (3.6) | 2.5–17.5 | 8.1 (3.8) | ||
6MWT saturation 85–89 (n = 20 at hospitalization) (n = 20 at 3-month follow-up) | 8.0–24.0 | 16.2 (4.1) | 3.5–18.5 | 10.3 (4.5) | ||
6MWT saturation ≤ 84 (n = 5 at hospitalization) (n = 5 at 3-month follow-up) | 10.0–18.0 | 14.2 (3.5) | 3.5–9.0 | 6.6 (2.6) | ||